Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Roundtable
Sort By
Newest First
1 / 5
1 / 5
Gene Editing
What are the key ethical and regulatory considerations as gene editing technologies advance toward widespread clinical use?
Pharma's Almanac
PAO-0-25-RT-02
Jun 17, 2025
Health Equity
How is the pharmaceutical industry addressing global health inequities?
Pharma's Almanac
PAO-0-25-RT-01
Jun 17, 2025
Next-Gen Biologics
What do you see as the next big modality in biologics, and what factors are driving innovation in this space?
Pharma's Almanac
PAO-04-25-RT-01
May 01, 2025
Drug Approvals
How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?
Pharma's Almanac
PAO-03-25-RT-01
Mar 26, 2025
RNA
What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?
Pharma's Almanac
PAO-03-25-RT-02
Mar 26, 2025
AI
Is AI truly transforming drug development, or are we still navigating through the hype?
Pharma's Almanac
PAO-02-25-RT-01
Feb 26, 2025
Supply Chain
What strategies are ensuring supply chain resilience in a post-COVID world?
Pharma's Almanac
PAO-02-25-RT-02
Feb 26, 2025
Sustainability
How can pharma manufacturing align with green initiatives while maintaining efficiency and compliance?
Pharma's Almanac
PAO-01-25-RT-02
Jan 31, 2025
Personalized
How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead?
Pharma's Almanac
PAO-01-25-RT-01
Jan 31, 2025
Innovation
How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?
Pharma's Almanac
PAO-11-24-RT-02
Oct 28, 2024
BIOSECURE Act
Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?
Pharma's Almanac
PAO-11-24-RT-01
Oct 28, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01
Aug 07, 2024
Global Access
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Pharma's Almanac
PAO-08-24-RT-02
Aug 07, 2024
Digitalization
How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
Pharma's Almanac
PAO-06-24-RT-02
Jun 24, 2024
Investment
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Pharma's Almanac
PAO-06-24-RT-01
Jun 24, 2024
Commitment to ESG Principles
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Pharma's Almanac
PAO-03-24-CL-03
Mar 08, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02
Mar 08, 2024
Roundtable
What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?
Pharma's Almanac
PAO-12-23-RT-02
Dec 15, 2023
Roundtable
What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?
Pharma's Almanac
PAO-12-23-RT-01
Dec 14, 2023
Real-World Data
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
Pharma's Almanac
PAO-09-23-RT-01
Sep 15, 2023
